McKesson Retained Earnings (Accumulated Deficit) 2010-2024 | MCK
McKesson retained earnings (accumulated deficit) from 2010 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
- McKesson retained earnings (accumulated deficit) for the quarter ending June 30, 2024 were $15.810B, a 19.94% increase year-over-year.
- McKesson retained earnings (accumulated deficit) for 2024 were $14.978B, a 21.82% increase from 2023.
- McKesson retained earnings (accumulated deficit) for 2023 were $12.295B, a 36.16% increase from 2022.
- McKesson retained earnings (accumulated deficit) for 2022 were $9.03B, a 10.1% increase from 2021.
McKesson Annual Retained Earnings (Accumulated Deficit)
(Millions of US $) |
| 2024 |
$14,978 |
| 2023 |
$12,295 |
| 2022 |
$9,030 |
| 2021 |
$8,202 |
| 2020 |
$13,022 |
| 2019 |
$12,409 |
| 2018 |
$12,986 |
| 2017 |
$13,189 |
| 2016 |
$8,360 |
| 2015 |
$12,705 |
| 2014 |
$11,453 |
| 2013 |
$10,402 |
| 2012 |
$9,451 |
| 2011 |
$8,250 |
| 2010 |
$7,236 |
| 2009 |
$6,103 |
McKesson Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $) |
| 2024-06-30 |
$15,810 |
| 2024-03-31 |
$14,978 |
| 2023-12-31 |
$14,268 |
| 2023-09-30 |
$13,761 |
| 2023-06-30 |
$13,182 |
| 2023-03-31 |
$12,295 |
| 2022-12-31 |
$11,582 |
| 2022-09-30 |
$10,579 |
| 2022-06-30 |
$9,732 |
| 2022-03-31 |
$9,030 |
| 2021-12-31 |
$8,734 |
| 2021-09-30 |
$8,812 |
| 2021-06-30 |
$8,618 |
| 2021-03-31 |
$8,202 |
| 2020-12-31 |
$7,595 |
| 2020-09-30 |
$13,890 |
| 2020-06-30 |
$13,384 |
| 2020-03-31 |
$13,022 |
| 2019-12-31 |
$12,075 |
| 2019-09-30 |
$11,965 |
| 2019-06-30 |
$12,770 |
| 2019-03-31 |
$12,409 |
| 2018-12-31 |
$13,276 |
| 2018-09-30 |
$13,354 |
| 2018-06-30 |
$12,932 |
| 2018-03-31 |
$12,986 |
| 2017-12-31 |
$14,202 |
| 2017-09-30 |
$13,370 |
| 2017-06-30 |
$13,442 |
| 2017-03-31 |
$13,189 |
| 2016-12-31 |
$9,663 |
| 2016-09-30 |
$9,088 |
| 2016-06-30 |
$8,843 |
| 2016-03-31 |
$8,360 |
| 2015-12-31 |
$7,995 |
| 2015-09-30 |
$13,780 |
| 2015-06-30 |
$13,227 |
| 2015-03-31 |
$12,705 |
| 2014-12-31 |
$12,628 |
| 2014-09-30 |
$12,211 |
| 2014-06-30 |
$11,800 |
| 2014-03-31 |
$11,453 |
| 2013-12-31 |
$11,138 |
| 2013-09-30 |
$11,130 |
| 2013-06-30 |
$10,780 |
| 2013-03-31 |
$10,402 |
| 2012-12-31 |
$10,384 |
| 2012-09-30 |
$10,135 |
| 2012-06-30 |
$9,783 |
| 2012-03-31 |
$9,451 |
| 2011-12-31 |
$8,981 |
| 2011-09-30 |
$8,731 |
| 2011-06-30 |
$8,486 |
| 2011-03-31 |
$8,250 |
| 2010-12-31 |
$7,876 |
| 2010-09-30 |
$7,767 |
| 2010-06-30 |
$7,488 |
| 2010-03-31 |
$7,236 |
| 2009-12-31 |
$6,921 |
| 2009-09-30 |
$6,627 |
| 2009-06-30 |
$6,358 |
| 2009-03-31 |
$6,103 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$66.345B |
$308.951B |
|
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
|
